KR830004215A - 환상 펩티드핵 - Google Patents

환상 펩티드핵 Download PDF

Info

Publication number
KR830004215A
KR830004215A KR1019800004736A KR800004736A KR830004215A KR 830004215 A KR830004215 A KR 830004215A KR 1019800004736 A KR1019800004736 A KR 1019800004736A KR 800004736 A KR800004736 A KR 800004736A KR 830004215 A KR830004215 A KR 830004215A
Authority
KR
South Korea
Prior art keywords
cyclic peptide
stearoyl
formula
peptide nucleus
nucleus
Prior art date
Application number
KR1019800004736A
Other languages
English (en)
Other versions
KR840000769B1 (ko
Inventor
존 애보트 버나드
슈이찌 후꾸다 데비드
Original Assignee
아더 알 웨일
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/181,449 external-priority patent/US4299762A/en
Priority claimed from US06/181,443 external-priority patent/US4293490A/en
Priority claimed from US06/181,029 external-priority patent/US4293482A/en
Priority claimed from US06/181,437 external-priority patent/US4299763A/en
Priority claimed from US06/181,036 external-priority patent/US4304716A/en
Application filed by 아더 알 웨일, 일라이 릴리 앤드 캄파니 filed Critical 아더 알 웨일
Publication of KR830004215A publication Critical patent/KR830004215A/ko
Application granted granted Critical
Publication of KR840000769B1 publication Critical patent/KR840000769B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62—Streptosporangium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음

Description

환상 펩티드핵
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도 : A-30912A핵의 적외부 흡수 스펙트럼

Claims (1)

  1. 다음 일반식(Ⅱ)의 환상 펩티드 항생물질과 악티노플라나세과 미생물이 생성한 탈아실화 효소를 수성매질중에서 접촉시키는 것을 특징으로 하여 다음 일반식(I)의 환상펩티드핵 및 그의 산부가염을 제조하는 방법.
    상기식에서
    R1은 H 또는 OH인데;
    R1이 H일때, R2는 H이며, R3및 R4는 모두 H 또는 OH이고,
    R은 스테아로일 또는 리놀레오일이고,
    R1이 OH일때, R2는 H이고, R3은 OH이고, R4도 OH이고, R은 스테아로일, 리놀레오닐 또는 팔미토일이거나, R3가 C1-C6알킬옥시이고,
    R은 스테아로일 또는 리놀레오일이거나
    R3,R4모두 OH이고 R2는이고,
    R은 미리스토일이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800004736A 1979-12-13 1980-12-12 환상 펩티드핵의 제조방법 KR840000769B1 (ko)

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US10301779A 1979-12-13 1979-12-13
US10312179A 1979-12-13 1979-12-13
US10326879A 1979-12-13 1979-12-13
US10301679A 1979-12-13 1979-12-13
US10331379A 1979-12-13 1979-12-13
US103,017 1979-12-13
US103,016 1979-12-13
US103,313 1979-12-13
US103,268 1979-12-13
US103,121 1979-12-13
US06/181,449 US4299762A (en) 1979-12-13 1980-08-25 A-30912D Nucleus
US181,029 1980-08-25
US181,036 1980-08-25
US06/181,443 US4293490A (en) 1979-12-13 1980-08-25 A-30912H Nuclei
US06/181,029 US4293482A (en) 1979-12-13 1980-08-25 A-30912A Nucleus
US06/181,437 US4299763A (en) 1979-12-13 1980-08-25 A-30912B Nucleus
US181,449 1980-08-25
US06/181,036 US4304716A (en) 1979-12-13 1980-08-25 S 31794/F-1 Nucleus
US181,443 1980-08-25
US181,437 1980-08-25

Publications (2)

Publication Number Publication Date
KR830004215A true KR830004215A (ko) 1983-07-06
KR840000769B1 KR840000769B1 (ko) 1984-06-08

Family

ID=27580999

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800004736A KR840000769B1 (ko) 1979-12-13 1980-12-12 환상 펩티드핵의 제조방법

Country Status (17)

Country Link
EP (1) EP0031221B1 (ko)
JP (1) JPS6425797A (ko)
KR (1) KR840000769B1 (ko)
CA (1) CA1170598A (ko)
CH (1) CH646701A5 (ko)
DD (1) DD155250A5 (ko)
DE (1) DE3062235D1 (ko)
DK (1) DK528680A (ko)
FI (1) FI803872L (ko)
FR (1) FR2484451B1 (ko)
GB (1) GB2065131B (ko)
GR (1) GR72254B (ko)
IL (1) IL61651A (ko)
IT (1) IT1141151B (ko)
PL (1) PL228450A1 (ko)
PT (1) PT72153B (ko)
YU (1) YU311080A (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1138149B (it) * 1980-08-15 1986-09-17 Sandoz Ag Metaboliti,loro preparazione e loro impiego in terapeutica
US4322406A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Antibiotic A-4696 factors B1, B2, B3, C1a, C3 and E1
NZ199196A (en) * 1980-12-18 1985-01-31 Lilly Co Eli Antibiotic a-4696 factor g and growth-promoting compositions;actinoplanes missouriensis atcc 31681
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4587218A (en) * 1983-10-21 1986-05-06 Eli Lilly And Company Novel bioconverting microorganisms
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
WO2000052037A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin/carbohydrate complexes
CA2362481C (en) 1999-03-03 2008-11-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
KR20020002476A (ko) * 1999-03-03 2002-01-09 피터 지. 스트링거 결정질 에키노칸딘 암모늄염의 형성 및 음이온 교환
CA2362482A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
CN102618606B (zh) * 2011-01-30 2014-09-10 浙江海正药业股份有限公司 一种棘白菌素生物转化方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
JPS5134916B2 (ko) * 1974-03-06 1976-09-29
ES449582A1 (es) * 1975-07-08 1977-12-01 Sandoz Ag Procedimiento para la produccion de s 31794nf-1.
US4024246A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-22082 and process for production thereof
IE43663B1 (en) * 1975-10-02 1981-04-22 Lilly Co Eli Antibiotic and process for production thereof
GR61684B (en) * 1975-10-02 1978-12-09 Lilly Co Eli Preparation process of antibiotic a-22082
US4024245A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-30912 and process for production thereof
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
DE2742435A1 (de) * 1976-09-28 1978-04-06 Sandoz Ag Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
DE2803584A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Aminoalkylaether der peptide tetrahydro-sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
DE2803581A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Derivate des tetrahydro-echinocandin b
BE883593A (fr) * 1979-06-08 1980-12-02 Lilly Co Eli Nouveaux antibiotiques, leur preparation et leur utilisation therapeutique

Also Published As

Publication number Publication date
YU311080A (en) 1983-02-28
FR2484451A1 (fr) 1981-12-18
IL61651A0 (en) 1981-01-30
GB2065131B (en) 1983-06-22
DE3062235D1 (de) 1983-04-07
DK528680A (da) 1981-06-14
IT1141151B (it) 1986-10-01
PL228450A1 (ko) 1981-08-07
KR840000769B1 (ko) 1984-06-08
FI803872L (fi) 1981-06-14
DD155250A5 (de) 1982-05-26
JPH0353320B2 (ko) 1991-08-14
IL61651A (en) 1984-04-30
PT72153B (en) 1981-10-28
EP0031221A1 (en) 1981-07-01
JPS6425797A (en) 1989-01-27
FR2484451B1 (fr) 1985-12-06
GB2065131A (en) 1981-06-24
PT72153A (en) 1981-01-01
GR72254B (ko) 1983-10-06
CH646701A5 (fr) 1984-12-14
IT8026634A0 (it) 1980-12-12
EP0031221B1 (en) 1983-03-02
CA1170598A (en) 1984-07-10

Similar Documents

Publication Publication Date Title
KR830004215A (ko) 환상 펩티드핵
KR830005849A (ko) 수중에서 이버멕틴의 용매화
KR910021234A (ko) 이리도이드 글리코시드 및 그 애글리콘에 의한 모발 염색 방법 및 이 방법에 사용되는 조성물
KR840009031A (ko) 니모디핀-함유 제제의 제조방법
KR830003531A (ko) 섬유 형성 코폴리에스테르
GB1231228A (ko)
IE45478L (en) Benzopyran derivatives
KR870009711A (ko) 장파 자외선 흡수제 및 이를 함유하는 화장품
KR890000486A (ko) 신규한 방법
KR830004414A (ko) 마이코페놀산 유도체의 제조방법
KR830010194A (ko) 미토콘드리아 dna 를 이용한 하이브리드 벡터
KR830003420A (ko) 피롤리딘 유도체
KR840007437A (ko) 항생제 a 51568 인자 a 및 b의 제조방법
JPS52146952A (en) Fold door
KR890004994A (ko) 신규 백금 착화합물
KR830005149A (ko) 4'-(9-아크리디닐아미노)메탄설폰-m-아니시다이드 염의 제법
KR840005754A (ko) 탄 성 사
KR850001228A (ko) (8s)-8-플루오로에리트로마이신의 제조방법
KR870001137A (ko) 1,1-(3-에틸페닐) 페닐에틸렌 및 그제법
KR900000474A (ko) 5'-이노신산(5'-Inosinic Acid)을 생산하는 미생물
KR850007126A (ko) 워드프로우세서의 괘선 편집방법
KR920007562A (ko) 효모 엑기스의 제조방법
KR870008535A (ko) "밤"가루(율분)
KR850002610A (ko) 영구기관 제47호기
KR850008268A (ko) 고기 두부 제조방법